Forget nta, theyre already talking write downs. So much for acquiring the teva and all the other tag ons at the purported 6*ebit....im yet to see proof of that valuation, earning acretive, yeah right, more like value trap.
mngt need to be held accountable. Failed to remedy supply chain issues they keep blaming, failed to handle obsolescence, failed with the sales drive...not seen any of it.
we're losing money (shareholders) and all we get is stupid updates blaming any1 but themselves. Reading the brief, its the same excuses....they give us a hint of "but we're expecting next qtr, year blah blah blah...to miraculously be better." Only to get worse and same issues as outlined above.
generics is their core business....cant even get that right. not happy.heeps of other much better value opps out there- may take the hit on half my portfolio...
MYX Price at posting:
56.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)